Company
Casdin Capital
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| City Therapeutics, Inc. | Series B | 2026-06-09 | |
| Beacon Biosignals | Series B | 2025-11-13 | |
| Octave Bioscience | Series C | 2025-09-05 | |
| TMRW Life Sciences | Series D Financing | 2024-07-24 | |
| Thyme Care | Series B Funding | 2023-08-22 | |
| Octave Bioscience | Series B Extension | 2023-07-26 | |
| Septerna | Series B Financing | 2023-07-17 | |
| Function Oncology | Series A Funding | 2023-04-12 | |
| Flare Therapeutics | Series B Financing | 2023-03-22 | |
| Chroma Medicine | Series B Financing | 2023-03-01 | |
| Nest Genomics | Seed | 2023-01-11 | |
| IDRx | Series A | 2022-08-02 | Lead |